These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 34421902)
1. BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity. Eggenhuizen PJ; Ng BH; Chang J; Fell AL; Cheong RMY; Wong WY; Gan PY; Holdsworth SR; Ooi JD Front Immunol; 2021; 12():692729. PubMed ID: 34421902 [TBL] [Abstract][Full Text] [Related]
2. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2. Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD Front Immunol; 2021; 12():812176. PubMed ID: 35095907 [TBL] [Abstract][Full Text] [Related]
3. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis. Tomita Y; Sato R; Ikeda T; Sakagami T Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070 [TBL] [Abstract][Full Text] [Related]
4. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques. White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S Front Immunol; 2021; 12():801799. PubMed ID: 35222355 [TBL] [Abstract][Full Text] [Related]
5. Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria. Eggenhuizen PJ; Ng BH; Chang J; Cheong RMY; Yellapragada A; Wong WY; Ting YT; Monk JA; Gan PY; Holdsworth SR; Ooi JD Front Immunol; 2022; 13():821595. PubMed ID: 35154139 [TBL] [Abstract][Full Text] [Related]
6. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019. Ma Y; Liu F; Lin T; Chen L; Jiang A; Tian G; Nielsen M; Wang M J Infect Dis; 2021 Sep; 224(6):956-966. PubMed ID: 34145459 [TBL] [Abstract][Full Text] [Related]
7. Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base. Nachega JB; Maeurer M; Sam-Agudu NA; Chakaya J; Katoto PDM; Zumla A Int J Infect Dis; 2021 Dec; 113 Suppl 1():S78-S81. PubMed ID: 33794380 [TBL] [Abstract][Full Text] [Related]
8. Are BCG-induced non-specific effects adequate to provide protection against COVID-19? Vashishtha VM Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516 [TBL] [Abstract][Full Text] [Related]
9. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals. Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082 [TBL] [Abstract][Full Text] [Related]
10. Convergence between global BCG vaccination and COVID-19 pandemic. Islam MZ; Zahan MK; Al-Bari MAA J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313 [TBL] [Abstract][Full Text] [Related]
11. Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19? Finotti P Cell Stress Chaperones; 2022 Jan; 27(1):37-43. PubMed ID: 34755305 [TBL] [Abstract][Full Text] [Related]
12. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers. Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672 [TBL] [Abstract][Full Text] [Related]
13. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2. Sharma D Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516 [TBL] [Abstract][Full Text] [Related]
14. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates. Behr MA; Divangahi M; Schurr E J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614 [TBL] [Abstract][Full Text] [Related]
18. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y Front Immunol; 2020; 11():596684. PubMed ID: 33362779 [TBL] [Abstract][Full Text] [Related]
19. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Charoenlap S; Piromsopa K; Charoenlap C Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943 [TBL] [Abstract][Full Text] [Related]